The family of a severely epileptic girl who uses medicinal cannabis to reduce her daily seizures from 300 to 10, worry the coronavirus crisis will abruptly stop their ability to source the remedy.
An increasing number of patients are turning to cannabis and cannabinoids for management of their palliative and nonpalliative cancer pain and other cancer-related symptoms.
Edible products and pre-rolled joints are out. Vape concentrates and loose “flower,” which can be packed into bongs or pipes or rolled into joints and provide more bang for the buck, are in.
As the nation rushes to slow the COVID-19 pandemic, the cannabis industry finds itself caught in the chaos like everyone else.
Marijuana sales are booming, with some states seeing 20 percent spikes in sales as anxious Americans prepare to be hunkered down in their homes potentially for months. Weed sellers are staffing up too, hiring laid-off workers from other industries to meet demand.
South Florida State College project manager Kendall Carson, left, and Oviedo entrepreneur Steve Edmonds place a cannabis biomat onto Lake Glenada.
So many myths surround the positive effects of cannabis that it’s often difficult to separate truth from mere presumption.
The effects of infotainment systems on driving performance is comparable to that of alcohol and cannabis, the findings of a new study have revealed.
There is unlikely to be any progress unless governments start treating their legal cannabis sectors as essential, as right now, that designation appears to provide none of the expected benefits.
After nearly 4 years of what some researchers saw as foot dragging, the Drug Enforcement Administration (DEA) has announced it will evaluate 37 applications to grow marijuana for medical research and proposed new rules for the prospective growers that outline how the cannabis-growing program would work.